Article
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance
2024-07-15
Abstract excerpt
<title>Abstract</title> <p>Colorectal Cancer (CRC) is a devastating disease, ranking second in cancer-related deaths. Immune checkpoint inhibitors (ICIs) have reshaped the prognosis of many cancers, including Microstatellite Instable (MSI) CRC. However, a significant proportion of MSI patients do not benefit from immunotherapy, prompting the selection of patients based on factors beyond microsatellite status. Mor...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 09d8822c-2598-5855-95d8-c29dd5e253d6
- DOI
- 10.21203/rs.3.rs-4497628/v1
